tradingkey.logo

tradingkey.logo
怜玢


Genenta Science SPA

GNTA
りォッチリストに远加
0.710USD
-0.045-5.96%
終倀 10-08 16:00ET
16.64M時䟡総額
損倱額盎近12ヶ月PER
前堎取匕 04:20 (ET)0.742USD+0.032+4.51%

Genenta Science SPAに぀いお 䌁業名

Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.

Genenta Science SPA プロフィヌル


䌁業コヌドGNTA
䌚瀟名Genenta Science SPA
䞊堎日Dec 15, 2021
最高経営責任者「CEO」Paracchi (Pierluigi)
埓業員数13
蚌刞皮類Depository Receipt
決算期末Dec 15
本瀟所圚地Via Olgettina 58
郜垂MILANO
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Italy
郵䟿番号20132
電話番号
りェブサむトhttps://www.genenta.com/
䌁業コヌドGNTA
䞊堎日Dec 15, 2021
最高経営責任者「CEO」Paracchi (Pierluigi)

Genenta Science SPAの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chief Executive Officer, Chairman of the Board and General Manager
Chief Executive Officer, Chairman of the Board and General Manager
2.43M
+5.34%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
--
Dr. Stefania Mazzoleni, Ph.D.
Dr. Stefania Mazzoleni, Ph.D.
Scientific Project Manager, Communication Officer
Scientific Project Manager, Communication Officer
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--
Dr. Armon Reza Sharei, Ph.D.
Dr. Armon Reza Sharei, Ph.D.
Independent Director
Independent Director
--
--
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
--
--
Ms. Barbara Regonini
Ms. Barbara Regonini
Vice President - Finance and Group Integration
Vice President - Finance and Group Integration
--
--
Dr. Francesco Galimi, M.D., Ph.D.
Dr. Francesco Galimi, M.D., Ph.D.
Non-Independent Director, Acting Chief Medical Officer and Head of Development
Non-Independent Director, Acting Chief Medical Officer and Head of Development
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chief Executive Officer, Chairman of the Board and General Manager
Chief Executive Officer, Chairman of the Board and General Manager
2.43M
+5.34%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
--
Dr. Stefania Mazzoleni, Ph.D.
Dr. Stefania Mazzoleni, Ph.D.
Scientific Project Manager, Communication Officer
Scientific Project Manager, Communication Officer
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--

よくある質問

Genenta Science SPAの䞊䜍5名の株䞻は誰ですか


Genenta Science SPAの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Pierluigi Paracchi

Genenta Science SPAGNTAの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Genenta Science SPAの株匏を保有しおいる機関は24瀟あり、保有株匏の総垂堎䟡倀は玄3.34Mで、党䜓の14.15%を占めおいたす。2025Q4ず比范しお、機関の持ち株は1015532.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。